STAT3 has been considered as a potential target in a series of diseases, including cancer and immune disorders; therefore, we wondered whether STAT3 could be a suitable pharmacological target to regulate bone metabolism and bone homeostasis. This evidence concerns the gene STAT3 and immune system disorder.